Thol, F., & Hofmann, W. (2012). Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood, 119(15), . https://doi.org/10.1182/blood-2011-12-399337
Chicago Style (17th ed.) CitationThol, Felicitas, and Wolf-Karsten Hofmann. "Frequency and Prognostic Impact of Mutations in SRSF2, U2AF1, and ZRSR2 in Patients with Myelodysplastic Syndromes." Blood 119, no. 15 (2012). https://doi.org/10.1182/blood-2011-12-399337.
MLA (9th ed.) CitationThol, Felicitas, and Wolf-Karsten Hofmann. "Frequency and Prognostic Impact of Mutations in SRSF2, U2AF1, and ZRSR2 in Patients with Myelodysplastic Syndromes." Blood, vol. 119, no. 15, 2012, https://doi.org/10.1182/blood-2011-12-399337.
Warning: These citations may not always be 100% accurate.